William D. McClellan Jr.

Insider Reports History

Entity
Individual
Location
C/O Apollo Endosurgery, Inc., 1120 S., Capital Of Texas Hwy, Bldg. 1, Suite 300, Austin, TX
Signature
/s/ Tracy Herson, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by William D. McClellan Jr.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Apollo Endosurgery, Inc. Director Common Stock 0 $6.46 Apr 4, 2023 by Trust
Apollo Endosurgery, Inc. Director Common Stock 0 $6.46 Apr 4, 2023 Direct
Apollo Endosurgery, Inc. Director Stock Option (Right to Buy) 0 $8.86 Apr 4, 2023 Direct
REATA PHARMACEUTICALS INC Director Class A common stock 0 $172.03 Sep 26, 2023 Direct
REATA PHARMACEUTICALS INC Director Stock Option (right to buy) 0 Sep 26, 2023 Direct

Insider Reports Filed by William D. McClellan Jr.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RETA REATA PHARMACEUTICALS INC Sep 26, 2023 12 $0 4 Sep 26, 2023 Director
RETA REATA PHARMACEUTICALS INC Jul 28, 2023 5 -$690K 4 Aug 1, 2023 Director
RETA REATA PHARMACEUTICALS INC Jun 7, 2023 4 $177K 4 Jun 9, 2023 Director
APEN Apollo Endosurgery, Inc. Apr 4, 2023 9 $0 4 Apr 4, 2023 Director
APEN Apollo Endosurgery, Inc. Jun 14, 2022 2 $0 4 Jun 16, 2022 Director
RETA REATA PHARMACEUTICALS INC Jun 8, 2022 4 $155K 4 Jun 9, 2022 Director
RETA REATA PHARMACEUTICALS INC Jan 3, 2022 2 $3.21K 4 Jan 5, 2022 Director
APEN Apollo Endosurgery, Inc. Jun 17, 2021 2 $46.7K 4 Jun 21, 2021 Director
RETA REATA PHARMACEUTICALS INC Jun 10, 2021 1 $0 4 Jun 14, 2021 Director